Cargando…
What Is the Purpose of the Orphan Drug Act?
Matthew Herder suggests it may be time to re-examine the purpose of the U.S. Orphan Drug Act.
Autor principal: | Herder, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207521/ https://www.ncbi.nlm.nih.gov/pubmed/28045908 http://dx.doi.org/10.1371/journal.pmed.1002191 |
Ejemplares similares
-
Adenylosuccinic Acid: An Orphan Drug with Untapped Potential
por: Rybalka, Emma, et al.
Publicado: (2023) -
Some Numbers behind Canada's Decision to Adopt an Orphan Drug Policy: US Orphan Drug Approvals in Canada, 1997–2012
por: Herder, Matthew, et al.
Publicado: (2016) -
Orphan drug incentives in the pharmacogenomic context: policy responses in the USA and Canada
por: Herder, Matthew
Publicado: (2016) -
On what basis did Health Canada approve OxyContin in 1996? A retrospective analysis of regulatory data
por: Pappin, Jessie, et al.
Publicado: (2022) -
The impact of the rare disease and Orphan Drug Act in Taiwan
por: Hsiang, Ning-Chun, et al.
Publicado: (2021)